New Therapeutic Targets Identified in Idiopathic Pulmonary Fibrosis (IPF)
Idiopathic pulmonary fibrosis (IPF) pathogenesis may soon have new therapeutic targets, according to multiomics research published in Respir Res in 2026 by Yue M et al. The progressive and irreversible interstitial lung disease, which carries a high mortality rate, has been linked to lactylation—a recently identified posttranslational modification. While researchers previously understood that lactylation contributes … Read more